NCT06857838 Myocardialbridge Bypass Graft Surgery Efficacy Verification
| NCT ID | NCT06857838 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xi'an International Medical Center Hospital |
| Condition | Myocardial Bridge of Coronary Artery |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2020-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Myocardial Bridge Bypass Graft surgery is introduced to relieve the unmedical symptoms of patients with long-segment or deep myocardial bridge, clinical outcomes will be collected to verify the effectiveness of the surgery.
Eligibility Criteria
Inclusion Criteria: * Patients with myocardialbridge requiring drug therapy or surgical intervention. Exclusion Criteria: * patients with myocardialbridge not requiring drug therapy or surgical intervention, or unwilling to be enrolled for any reason
Contact & Investigator
Zhen Wang, Doctorate
PRINCIPAL INVESTIGATOR
Xi'an International Medical Center Hospital Affiliated To Northwest University
Frequently Asked Questions
Who can join the NCT06857838 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Myocardial Bridge of Coronary Artery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06857838 currently recruiting?
Yes, NCT06857838 is actively recruiting participants. Contact the research team at wang.zhen@000516.cn for enrollment information.
Where is the NCT06857838 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT06857838 clinical trial?
NCT06857838 is sponsored by Xi'an International Medical Center Hospital. The principal investigator is Zhen Wang, Doctorate at Xi'an International Medical Center Hospital Affiliated To Northwest University. The trial plans to enroll 500 participants.